Support PenkeSarepta Therapeutics Inc - Trending symbols
Latest News of Sarepta Therapeutics Inc
| Date | Title | Read |
|---|---|---|
| 2025-05-06 23:17 | Stocks making the biggest moves after hours: Super Micro Computer, Wynn Resorts, Electronic Arts and more | Read |
| 2025-05-05 19:53 | INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT | Read |
| 2025-05-04 12:46 | Oppenheimer Predicts Up to ~840% Surge for These 2 ‘Strong Buy’ Stocks | Read |
| 2025-04-25 19:38 | INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT | Read |
| 2025-04-21 20:46 | INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT | Read |
| 2025-04-18 19:38 | Exploring 3 High Growth Tech Stocks In The US Market | Read |
| 2025-04-17 19:21 | INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT | Read |
| 2025-04-12 15:30 | INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT | Read |
Notifications
| Type | Notification | Date |
|---|---|---|
| RSI Oversold | Oversold RSI (Relative Strength Index) | 2025-05-07 |
Trends
| 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Other Comprehensive Income | -1,664 | 1,245 | -419 | -636 | -1,055 | 417 | -638 | 1,556 | 918 | |
| Income before Tax | -101,306 | -411,404 | -512,710 | 498,125 | -14,585 | -18,589 | -33,174 | 73,545 | 40,371 | |
| Net Income | -109,244 | -407,511 | -516,755 | 492,815 | -23,940 | -16,997 | -40,937 | 86,592 | 45,655 | |
| Depreciation and Amortization | 25,343 | 4,992 | 30,335 | -19,543 | 10,792 | 136 | 10,928 | -62,983 | -52,055 | |
| Operating Income | -106,833 | -31,255 | -138,088 | 4,569 | -133,519 | 112,677 | -20,842 | 45,467 | 24,625 | |
| Tax Provision | 7,938 | -3,893 | 4,045 | 5,310 | 9,355 | -1,592 | 7,763 | -13,047 | -5,284 | |
| Income Tax Expense | 7,938 | -3,893 | 4,045 | 5,310 | 9,355 | -1,592 | 7,763 | -13,047 | -5,284 | |
| Net Income from Continuing Operations | -109,244 | -399,421 | -508,665 | 484,725 | -23,940 | -16,997 | -40,937 | 86,592 | 45,655 | |
| EBIT | -131,355 | 24,522 | -106,833 | -31,255 | -138,088 | 25,927 | -112,161 | 113,716 | 1,555 | |
| EBITDA | -112,238 | 30,748 | -81,490 | -26,263 | -107,753 | 6,384 | -101,369 | 113,852 | 12,483 | |
| Net Interest Income | -15,953 | 330 | -15,623 | 2,004 | -13,619 | 3,663 | -9,956 | 12,394 | 2,438 | |
| Total Other Income Expense Net | -16,076 | -1,189 | -17,265 | 304 | -16,961 | -108,102 | -125,063 | 130,590 | 5,527 | |
| Net Debt | -539,005 | 98,232 | -440,773 | -536,708 | -977,481 | 881,071 | -96,410 | 368,086 | 271,676 | |
| Other Stockholders Equity | 3,490,658 | 31,063 | 3,521,721 | 32,586 | 3,554,307 | 580,461 | 4,134,768 | -4,135,074 | -306 |
Comments
How you think about this?